The content is available as a PDF (219.0 KB).
. 1992 Aug;30(2):115–117. doi: 10.1093/jac/30.2.115
Drugs against rhinoviruses
WIDAD AL-NAKIB
a, DAVID A J TYRRELL
a
WIDAD AL-NAKIB
aDepartment of Virology Royal Postgraduate Medical School, University of London, Hammersmlth Hospital, Du Cane Road, London W12 ONN
Find articles by WIDAD AL-NAKIB
DAVID A J TYRRELL
aDepartment of Virology Royal Postgraduate Medical School, University of London, Hammersmlth Hospital, Du Cane Road, London W12 ONN
Find articles by DAVID A J TYRRELL
aDepartment of Virology Royal Postgraduate Medical School, University of London, Hammersmlth Hospital, Du Cane Road, London W12 ONN
bPHIS Centre for Applied Microbiology and Research, Porton Down, Salisbury SF4 OJG, UK
Issue date 1992 Aug.
© 1992 The British Society for Antimicrobial Chemotherapy
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7109821 PMID: 1328133